Histrelin Pregnancy and Breastfeeding Warnings

Histrelin is also known as: Supprelin LA, Vantas

Histrelin Pregnancy Warnings

Histrelin has been assigned to pregnancy category X by the FDA. Animal studies have revealed evidence of teratogenicity. There are no data in human pregnancy. Histrelin is contraindicated in females who are, or may become, pregnant while receiving the drug.

Histrelin Breastfeeding Warnings

There are no data on the excretion of histrelin in to human milk. Histrelin is indicated for use in children and men only.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)